KLISBIO
KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-human study on nerve repair that is ongoing at the University of Zurich, Switzerland
KLISBIO
Industry:
Biotechnology Health Care Life Science Medical Device
Founded:
2014-07-31
Address:
Lomazzo, Lombardia, Italy
Country:
Italy
Website Url:
http://www.klis.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.56 M EUR
Technology used in webpage:
SPF Google Apps For Business BlueHost BlueHost DNS BlueHost Mail
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Morphodyne
Morphodyne is an unique 3D bioprinting technology platform.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Principia SGR
Principia SGR investment in Convertible Note - KLISBio
Principia SGR
Principia SGR investment in Series A - KLISBio
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - KLISBio
Official Site Inspections
http://www.klis.bio
- Host name: cluster-a.redirect.pizza
- IP address: 89.41.169.49
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "KLISBio"
KLISBio
KLISBio Co-Founder & CEO, Gabriele Grecchi, presenting our Company at the MedTech Summit 2020 in Los Angeles, USA.See details»
KLISBio - Crunchbase Company Profile & Funding
Contact Email [email protected] KLISBio is challenging the status quo in regenerative medicine by leveraging silk as a powerful, scalable and biocompatible scaffold …See details»
About Us | KLISBio
Segnalazioni o testimonianze di comportamenti riconducibili a discriminazioni, molestie, abusi, violenze o mobbing possono essere effettuate compilando, anche in forma anonima, il modulo …See details»
KLISBio Company Profile 2024: Valuation, Funding
KLISBio General Information Description. Developer of an innovative medical technology designed to find new tissue regeneration methods. The company's …See details»
KLISBio - Company Profile - Tracxn
Nov 28, 2024 KLISBio - Developer of regenerative implantable products by using silk fibroins. Raised a total funding of $8.58M over 8 rounds from 9 investors. Founded by Gabriel Grecchi, …See details»
KLISBio - LinkedIn
KLISBio | 3,707 followers on LinkedIn. Silk innovation for life sciences | KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms ...See details»
KLISBio Company Profile - Office Locations, Competitors ... - Craft
KLISBio has 5 employees at their 1 location and $8.88 m in total funding,. See insights on KLISBio including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
KLISBio – XYence | Gestione del risparmio ad alto …
Klis.bio. Posts navigation. Xyence Capital SGR S.p.A. sole shareholder company (Principia SGR until 17th May 2021) Registered in the Register of SGRs pursuant to art. 35 TUF Section of the AIF managers Via Fatebenefratelli n. 34, 20121 …See details»
KLISBio Overview | SignalHire Company Profile
KLISBio is a private company that has been in the industry for 8 years. The company currently specializes in the Medical Devices area. The position of the Co-Founder is occupied by …See details»
KLISBio - Products, Competitors, Financials, Employees, …
About KLISBio. KLISBio is a med-tech company. The company develops regenerative implantable products by using silk fibroins. The company leverages a silk-based technology platform to …See details»
KLISBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? ShowSee details»
KLISBio | KLISBio
[email protected]. Unforeseen events, coincidence and intuition are often breeding ground of great ideas, but turning those ideas into reality and excellence requires commitment, expertise …See details»
KLISBio - VentureRadar
Serum Bio-technology Unknown n/a Serum Biotech is a high-tech enterprise specialized in research, development, production and sales of antitoxin and antiserum products in China. …See details»
KLISBio - Contacts, Employees, Board Members, Advisors & Alumni
Silk-fibroin tissue engineering technology platformSee details»
KLISBio | KLISBio
KLIS (“silk” spelled backwards) and Bio represent the company’s commitment to utilizing the power of silk fibroin to promote an endogenous repair of human soft tissues. Both the …See details»
KLISBio | KLISBio
[email protected] KLISBio (Silk Biomaterials S.r.l.) announced Rodrigo Bianchi has been appointed as the new KLISBio Chairman of the Board. Effective Dec. 20th, 2021 Rodrigo …See details»
KLISBio (@KLISBio) - Twitter
Jan 13, 2022 The latest Tweets from KLISBio (@KLISBio). We are a #medtech #startup using silk fibroin to develop an innovative #tissue #engineering #technology that help human tissue …See details»
KLISBio | KLISBio
[email protected] Milan, Italy (June 1st, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based …See details»
KLISBio | KLISBio
[email protected]. Milan, Italy (March 21, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based …See details»